Christopher Colameco

634 total citations
9 papers, 341 citations indexed

About

Christopher Colameco is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Christopher Colameco has authored 9 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Christopher Colameco's work include Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Genomics and Diagnostics (3 papers). Christopher Colameco is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Genomics and Diagnostics (3 papers). Christopher Colameco collaborates with scholars based in United States. Christopher Colameco's co-authors include Angela DeMichele, Melissa Langer, Peter J. O’Dwyer, Amy S. Clark, Michael D. Feldman, Priti Lal, Susan M. Domchek, Kevin R. Fox, Kristi Gramlich and Maryann Gallagher and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Christopher Colameco

7 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Colameco United States	5	291	290	80	69	44	9	341
Kristi Gramlich United States	3	320 1.1×	274 0.9×	80 1.0×	55 0.8×	111 2.5×	4	386
Jon S. Dubois United States	3	209 0.7×	212 0.7×	61 0.8×	91 1.3×	65 1.5×	4	285
Ros Cutts United Kingdom	9	296 1.0×	268 0.9×	47 0.6×	209 3.0×	116 2.6×	15	431
Fouad Alchami United Kingdom	6	180 0.6×	180 0.6×	37 0.5×	76 1.1×	135 3.1×	8	321
Sarah Alexandrou Australia	7	165 0.6×	137 0.5×	43 0.5×	67 1.0×	130 3.0×	10	265
Michela Palleschi Italy	9	189 0.6×	133 0.5×	41 0.5×	75 1.1×	75 1.7×	46	281
Tong Luo United States	5	225 0.8×	204 0.7×	65 0.8×	63 0.9×	119 2.7×	10	312
Shana Thomas United States	5	181 0.6×	165 0.6×	72 0.9×	70 1.0×	65 1.5×	9	259
Pavel Bezecny United Kingdom	5	176 0.6×	200 0.7×	80 1.0×	102 1.5×	213 4.8×	8	371
Agnes Lteif United States	7	182 0.6×	195 0.7×	58 0.7×	102 1.5×	97 2.2×	16	300

Countries citing papers authored by Christopher Colameco

Since Specialization

Citations

This map shows the geographic impact of Christopher Colameco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Colameco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Colameco more than expected).

Fields of papers citing papers by Christopher Colameco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Colameco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Colameco. The network helps show where Christopher Colameco may publish in the future.

Co-authorship network of co-authors of Christopher Colameco

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Colameco. A scholar is included among the top collaborators of Christopher Colameco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Colameco. Christopher Colameco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

McAndrew, Nicholas P., Mark A. Dickson, Amy S. Clark, et al.. (2020). Early treatment-related neutropenia predicts response to palbociclib. British Journal of Cancer. 123(6). 912–918. 17 indexed citations

McAndrew, Nicholas P., Mark A. Dickson, Amy S. Clark, et al.. (2018). Neutropenia and response to single agent palbociclib.. Journal of Clinical Oncology. 36(15_suppl). 1043–1043.

Maxwell, Kara N., Emin Tahirović, Andrea B. Troxel, et al.. (2017). Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer. Breast Cancer Research and Treatment. 164(3). 627–638. 19 indexed citations

Colameco, Christopher, Jennifer J.D. Morrissette, David Lieberman, et al.. (2016). Abstract P6-07-05: Mutational spectrum and tumor response in metastatic breast cancer. Cancer Research. 76(4_Supplement). P6–7. 1 indexed citations

DeMichele, Angela, María Koehler, Yuqiu Jiang, et al.. (2016). Abstract P4-13-04: Upregulation of cell cycle pathway genes without loss of RB1 contributes to acquired resistance to single-agent treatment with palbociclib in breast cancer. Cancer Research. 76(4_Supplement). P4–13. 3 indexed citations

O’Dwyer, Peter J., Andrea B. Troxel, Priti Lal, et al.. (2016). Abstract P6-13-08: Palbociclib and paclitaxel on an alternating schedule for advanced breast cancer: Results of a phase Ib trial. Cancer Research. 76(4_Supplement). P6–13. 5 indexed citations

Maxwell, Kara N., Brandon M. Wenz, Bradley Wubbenhorst, et al.. (2015). Characteristics of high risk breast cancer patients with mutations identified by multiplex panel testing.. Journal of Clinical Oncology. 33(15_suppl). 1511–1511.

DeMichele, Angela, Amy S. Clark, Kay See Tan, et al.. (2014). CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment. Clinical Cancer Research. 21(5). 995–1001. 280 indexed citations

Clark, Amy S., Peter J. O’Dwyer, Daniel F. Heitjan, et al.. (2014). A phase I trial of palbociclib and paclitaxel in metastatic breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 527–527. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact